Heart2Heart for Teens With CHD

Creating a Mobile Health Program for Teens With Congenital Heart Disease

Registry ID
NCT07764510
Source registry
NCT
Status
NOT_YET_RECRUITING
Phase
NA
Study type
INTERVENTIONAL
Sponsor
Kristen Fox
Enrollment
90
Start date
2026-08-17
Completion date
2028-07-31
Last update
2026-08-14

Conditions

Summary

The goal of this clinical trial is to learn if teens living with congenital heart disease like and will use Heart2Heart and if it affects how they think and feel about e-cigarettes. Heart2Heart is a website that provides health information for teens with congenital heart disease. The main questions this trial aims to answer are: * Will teens enroll in the trial and complete the trial activities? * Do teens use and like Heart2Heart? * Does using Heart2Heart affect how teens think and feel about e-cigarettes? Researchers will compare the Heart2Heart group to a group that does not use Heart2Heart to see if it affects teens' thoughts and feelings about e-cigarettes. Participants will: * Complete online surveys * If assigned, explore the Heart2Heart website * If invited, share their opinions about Heart2Heart in an online discussion

Interventions

Inclusion criteria

Inclusion Criteria: * 12-18 years of age * diagnosis of structural congenital heart disease * if under 18, has a parent or legal guardian proficient in English or Spanish

Exclusion criteria

Exclusion Criteria: * teen not proficient in English * teen has cognitive impairments that interfere with completion of the study activities * teen was a participant in one of the Heart2Heart development studies * teen does not have access to a device that can connect to the internet * teen is leaving the United States during their study period

Primary outcomes

[{"measure":"Percent of participants completing trial activities (Feasibility)","timeFrame":"Feasibility will be evaluated throughout the recruitment, enrollment, and data collection process."},{"measure":"Percent of participants with favorable satisfaction and usability ratings (Acceptability)","timeFrame":"Acceptability will be measured at the post-intervention survey, two weeks after participants are assigned to a study group."}]

Related clinical trials

View on source registry